Allergan can finally sell its losing stake in Teva. Will it? | FiercePharma
Teva Pharmaceuticals Garrett Hoffman S Agenda S Company
Teva Pharmaceuticals
A huge suit simply removed $2.5 billion from drug huge Teva's market cap. Here's just how much Teva and competing drugmaker Mylan might stand to lose in court. - Science and Tech News
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
TEVA Stock Price and Chart — TASE:TEVA — TradingView